| Browse All

MediWound Ltd. (MDWD)

Healthcare | Biotechnology | Yavne, Israel | NasdaqGM
17.04 USD -0.32 (-1.816%) ⇩ (April 21, 2026, 11:12 a.m. EDT)

Short-term: ★★★☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆
Hot Take | April 19, 2026, 1:18 a.m. EDT

MDWD is a dangerous long-term hold due to deteriorating fundamentals (negative growth, losses) but presents a mixed short-term setup where <strong>bullish short-term traders (Weeks) are fighting bearish hedge funds (Math/Treasury/Strategic)</strong>. The "Strong Buy" analyst rating is currently disconnected from the company's inability to generate free cash flow, making this a speculative momentum play only; avoid for long-term capital allocation.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.041647
AutoARIMA0.041819
AutoETS0.046713
AutoTheta0.054663

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 26%
H-stat 7.88
Ljung-Box p 0.000
Jarque-Bera p 0.008
Excess Kurtosis 1.21
Attribute Value
Sector Healthcare
Debt to Equity Ratio 20.111
Revenue per Share 1.491
Market Cap 218,938,160
Forward P/E -7.85
Beta 0.15
Profit Margins -140.80%
Website https://www.mediwound.com

As of April 19, 2026, 1:18 a.m. EDT: Speculators are positioning defensive put walls at near-term strikes (16.00/17.00) with high Open Interest, suggesting a potential struggle to hold current levels, yet the majority of volume is in OTM calls at 20.00/21.00 strikes. The April weekly show OTM call flow >12% over ITM calls, indicating a bullish bias among active traders attempting to break out past current resistance, despite the significant put support.


Info Dump

Attribute Value
52 Week Change -0.033426166
Address1 42 Hayarkon Street
All Time High 135.17
All Time Low 7.1
Ask 21.96
Ask Size 2
Average Analyst Rating 1.2 - Strong Buy
Average Daily Volume10 Day 91,530
Average Daily Volume3 Month 96,832
Average Volume 96,832
Average Volume10Days 91,530
Beta 0.152
Bid 12.32
Bid Size 2
Book Value 3.399
City Yavne
Compensation As Of Epoch Date 1,767,139,200
Country Israel
Crypto Tradeable 0
Currency USD
Current Price 17.035
Current Ratio 2.333
Custom Price Alert Confidence HIGH
Date Short Interest 1,774,915,200
Day High 17.36
Day Low 16.995
Debt To Equity 20.111
Display Name MediWound
Earnings Call Timestamp End 1,772,717,400
Earnings Call Timestamp Start 1,772,717,400
Earnings Timestamp 1,772,717,400
Earnings Timestamp End 1,779,280,200
Earnings Timestamp Start 1,779,280,200
Ebitda -24,280,000
Ebitda Margins -1.4316901
Enterprise To Ebitda -7.352
Enterprise To Revenue 10.526
Enterprise Value 178,507,264
Eps Current Year -2.88
Eps Forward -2.17
Eps Trailing Twelve Months -2.1
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 17.15
Fifty Day Average Change -0.11499977
Fifty Day Average Change Percent -0.0067055263
Fifty Two Week Change Percent -3.3426166
Fifty Two Week High 22.505
Fifty Two Week High Change -5.4699993
Fifty Two Week High Change Percent -0.24305707
Fifty Two Week Low 14.9
Fifty Two Week Low Change 2.1350002
Fifty Two Week Low Change Percent 0.14328861
Fifty Two Week Range 14.9 - 22.505
Financial Currency USD
First Trade Date Milliseconds 1,395,322,200,000
Float Shares 9,759,622
Forward Eps -2.17
Forward P E -7.85023
Free Cashflow -15,578,875
Full Exchange Name NasdaqGM
Full Time Employees 121
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.19187
Gross Profits 3,254,000
Has Pre Post Market Data 1
Held Percent Insiders 0.15855
Held Percent Institutions 0.57098
Implied Shares Outstanding 12,852,255
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,671,494,400
Last Split Factor 1:7
Long Business Summary MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Long Name MediWound Ltd.
Market us_market
Market Cap 218,938,160
Market State REGULAR
Max Age 86,400
Message Board Id finmb_1570881
Most Recent Quarter 1,767,139,200
Net Income To Common -23,879,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 222,986,624
Number Of Analyst Opinions 6
Open 17.36
Operating Cashflow -16,121,000
Operating Margins -4.1778297
Payout Ratio 0.0
Phone 972 7 797 14100
Previous Close 17.35
Price Eps Current Year -5.9149303
Price Hint 2
Price To Book 5.0117683
Price To Sales Trailing12 Months 12.909851
Profit Margins -1.40804
Quick Ratio 2.159
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key strong_buy
Recommendation Mean 1.16667
Region US
Regular Market Change -0.31500053
Regular Market Change Percent -1.815565
Regular Market Day High 17.36
Regular Market Day Low 16.995
Regular Market Day Range 16.995 - 17.36
Regular Market Open 17.36
Regular Market Previous Close 17.35
Regular Market Price 17.035
Regular Market Time 1,776,784,331
Regular Market Volume 10,447
Return On Assets -0.19770001
Return On Equity -0.6386
Revenue Growth -0.68
Revenue Per Share 1.491
Sand P52 Week Change 0.34445214
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 12,852,255
Shares Percent Shares Out 0.121199995
Shares Short 1,558,289
Shares Short Previous Month Date 1,772,150,400
Shares Short Prior Month 1,394,150
Short Name MediWound Ltd.
Short Percent Of Float 0.13859999
Short Ratio 19.21
Source Interval 15
Symbol MDWD
Target High Price 39.0
Target Low Price 25.0
Target Mean Price 31.33333
Target Median Price 31.5
Total Cash 53,140,000
Total Cash Per Share 4.137
Total Debt 8,775,000
Total Revenue 16,959,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -2.1
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 17.98485
Two Hundred Day Average Change -0.9498501
Two Hundred Day Average Change Percent -0.052813902
Type Disp Equity
Volume 10,447
Website https://www.mediwound.com
Zip 8,122,745